Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review

Review of 39 studies found that lifestyle and metformin interventions in high-risk individuals were cost-effective from the perspective of the US health care system and societal perspective (median ICERs of $12,510/QALY and $17,089/QALY, respectively, vs no intervention).


Diabetes Care